Related Experiment Video
Updated: Aug 13, 2026

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
Published on: August 6, 2014
Quantification of diazeniumdiolate mutagenicity in four different in vitro assays
P J Donovan1, G T Smith, T E Lawlor
1Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Maryland 21702-1201, USA.
Abstract:
Diazeniumdiolates are under investigation as possible prodrugs of the multifaceted bioregulatory agent nitric oxide. This study was undertaken to assess further the mutagenic potential of two diazeniumdiolates, DEA/NO (Et2N[N(O)NO]Na) and SPER/NO ([H2N(CH2)3NH(CH2)4N[N(O)NO-](CH2)3 NH3+]), which generate NO spontaneously with half-lives at 37 degrees C and pH 7.4 of 2 and 39 min, respectively. The genotoxic potential of these compounds was investigated with the Ames bacterial reverse mutation assay, two mammalian cell gene mutation assays (CHO/HGPRT and L5178Y TK+/-), and an assay for sister chromatid exchange (SCE) using Chinese hamster ovary (CHO) cells. Both diazeniumdiolates had previously been shown to be mutagenic in the Ames Salmonella plate assay. In the experiments reported here, Salmonella typhimurium strain TA1535 was exposed to the compounds in a liquid incubation assay for either 15 min or 48 h without an S-9 fraction. With the 15-min exposure, DEA/NO was mutagenic at concentrations of 0.625 mM (3.5 x control) and greater, while SPER/NO was mutagenic at 0.5 mM (2.7 x control) and above. In the CHO/HGPRT assay, DEA/NO was weakly mutagenic only at the highest concentration used, 20 mM, inducing a mutant frequency per survivor that was 2.5 x control, while SPER/NO was mutagenic at 0.5 mM with a mutant frequency of 2.5 x control. When the CHO cells were given 10 repetitive 20 mM DEA/NO exposures (3 min each), HGPRT mutant frequency was 4.1 x control. In the L5178Y mouse lymphoma cell TK+/- assay, DEA/NO doubled the mutation rate at 1.82 mM, while SPER/NO's mutation frequency was more than twice that of control at 0.63 mM. DEA/NO was positive in the SCE assay without metabolic activation, yielding significant SCE at 1.25, 2.5, and 5 mM that was 1.8, 2.2, and 2.6 times control, respectively. SPER/NO increased the SCE by 1.2, 1.4, and 1.3 times at 1.5, 2.0, and 2.5 mM. The results suggest that the two diazeniumdiolates, although mutagenic in the bacteria, are much weaker mutagens in mammalian cells.
Insights
This study assessed the mutagenic potential of two nitric oxide-releasing compounds, DEA/NO and SPER/NO. While mutagenic in bacteria, these diazeniumdiolates demonstrated significantly weaker mutagenic effects in mammalian cells.
Area of Science:
- Pharmacology and Toxicology
- Genetics and Molecular Biology
- Nitric Oxide Research
Background:
- Diazeniumdiolates are investigated as prodrugs for nitric oxide (NO), a key bioregulatory molecule.
- Understanding the genotoxic profile of NO-releasing compounds is crucial for their therapeutic development.
- DEA/NO and SPER/NO are diazeniumdiolates with distinct NO-release half-lives.
Purpose of the Study:
- To evaluate the mutagenic and genotoxic potential of DEA/NO and SPER/NO in bacterial and mammalian systems.
- To compare the genotoxicity of these compounds across different assays, including Ames test, mammalian cell gene mutation assays, and sister chromatid exchange (SCE) assay.
Main Methods:
- Bacterial reverse mutation assay (Ames test) using Salmonella typhimurium TA1535.
- Mammalian cell gene mutation assays: CHO/HGPRT and L5178Y TK+/-.
- Sister chromatid exchange (SCE) assay in Chinese hamster ovary (CHO) cells.
Main Results:
- Both DEA/NO and SPER/NO were mutagenic in Salmonella typhimurium.
- In mammalian cells, DEA/NO showed weak mutagenicity at high concentrations in the CHO/HGPRT assay, while SPER/NO was mutagenic at 0.5 mM.
- DEA/NO induced significant SCE in CHO cells, and SPER/NO also increased SCE, though to a lesser extent.
Conclusions:
- The diazeniumdiolates DEA/NO and SPER/NO exhibit mutagenic activity in bacteria.
- These compounds display considerably weaker mutagenic potential in mammalian cell-based assays compared to bacterial assays.
- Further investigation into the specific mechanisms of genotoxicity in mammalian systems is warranted.
Related Concept Videos
In vitro Mutagenesis
Mutagenicity and Carcinogenicity

